AF647 Anti-Human CD11a Antibody[TS1/22.1.1.13]

The AF647 Anti-Human CD11A Antibody [TS1/22.1.1.13] is a highly specific and reliable tool designed for the detection and analysis of CD11A expression in human samples. This monoclonal antibody, produced through advanced biotechnological methods, exhibits exceptional affinity and selectivity towards CD11A, a cell surface glycoprotein belonging to the integrin family.

With its AF647 fluorochrome conjugation, this antibody enables precise and efficient identification of CD11A-positive cells by flow cytometry, immunofluorescence, and immunohistochemistry techniques. The AF647 fluorochrome offers excellent photostability and brightness, ensuring accurate and reproducible results in various experimental settings.

The TS1/22.1.1.13 clone used in the production of this antibody has been extensively validated and characterized, guaranteeing consistent and reliable performance. It recognizes an epitope on the CD11A molecule that is highly conserved across different human tissues and cell types, making it an ideal tool for a wide range of applications.

This antibody is supplied as a liquid formulation, ready for immediate use. It has been optimized for minimal background staining and maximum signal-to-noise ratio, ensuring high sensitivity and specificity in CD11A detection. The AF647 Anti-Human CD11A Antibody [TS1/22.1.1.13] is provided in a convenient vial size, allowing for multiple experiments and reducing waste.

This product is manufactured under strict quality control standards, ensuring batch-to-batch consistency and reproducibility. It is suitable for use in both research and clinical settings, facilitating investigations into the role of CD11A in various physiological and pathological processes.

In summary, the AF647 Anti-Human CD11A Antibody [TS1/22.1.1.13] is a reliable and versatile tool for the detection and analysis of CD11A expression in human samples. Its high specificity, sensitivity, and ease of use make it an essential component of any study involving CD11A-mediated cellular interactions.